Pritesh Shah - 31 Jul 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Commercial Officer
Signature
By: /s/ Steven Robbins, Attorney in fact for Pritesh Shah
Issuer symbol
NVCR
Transactions as of
31 Jul 2021
Net transactions value
+$311,259
Form type
4
Filing time
11 Mar 2022, 15:54:08 UTC
Previous filing
08 Jul 2021
Next filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $572,455 +3,717 +4.5% $154.01* 85,625 31 Jul 2021 Direct
transaction NVCR Ordinary Shares Sale $261,196 -3,669 -4.2% $71.19 83,187 09 Mar 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Restricted Stock Units Options Exercise $0 -3,717 -50% $0.000000 3,717 31 Jul 2021 Ordinary Shares 3,717 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.
F2 Amended total to correct prior mathematical error.
F3 Fully vested as of the date hereof.